Graf Akcie ANGO (Angiodynamic Inc). Diskuze k akciím ANGO. Aktuální informace ANGO.

Základní informace o společnosti Angiodynamic Inc (Akcie ANGO)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 1000M
Hodnota podniku (EV) 892.96M
Tržby 297.765M
EBITDA 3.174M
Zisk -34.25
Růst v tržbách Q/Q 9.62 %
Růst v tržbách Y/Y 10.97 %
P/E (Cena vůči ziskům) N/A
Forward P/E 599.00
EV/Sales 3.00
EV/EBITDA 281.34
EV/EBIT N/A
PEG 5.96
Price/Sales 3.36
P/FCF 309.68
Price/Book 2.28
Účetní hodnota na akcii 12.04
Hotovost na akcii 1.32
FCF vůči ceně 0.32 %
Počet zaměstnanců 800
Tržba na zaměstnance 372.206k
Profit margin -10.84 %
Operating margin -12.50 %
Gross margin 53.88 %
EBIT margin -13.11 %
EBITDA margin 1.07 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -200.00 %
EPS - Očekávaný růst příští rok -100.00 %
Return on assets -5.99 %
Return on equity -7.68 %
ROIC -6.09 %
ROCE -7.75 %
Dluhy/Equity 0.28
Čistý dluh/EBITDA -25.56
Current ratio 2.52
Quick Ratio 1.57
Volatilita 4.20
Beta 1.14
RSI 59.59
Cílová cena analytiků 14
Známka akcie (dle analytiků) N/A
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 38.65M
Procento shortovaných akcií 2.28 %
Short ratio 2.49 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2004
Země United States

Finanční výsledky akcie ANGO

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$264.157$270.634$261.655$269.788$353.89$356.534
Cost Of Goods Sold$113.885$114.634$117.799$125.838$179.574$180.738
Gross Profit$150.272$156$143.856$143.95$174.316$175.796
Research And Development Expenses$29.682$28.258$24.338$24.148$25.053$26.594
SG&A Expenses$116.506$111.731$104.1$105.998$114.326$112.382
Other Operating Income Or Expenses$11.531$6.776$-0.25$17.098$-3.364$3.954
Operating Expenses$431.255$280.03$275.825$280.963$352.872$359.983
Operating Income$-167.098$-9.396$-14.17$-11.175$1.018$-3.449
Total Non-Operating Income/Expense$-1.037$-5.306$-3.093$-3.12$-4.271$-4.682
Pre-Tax Income$-168.135$-14.702$-17.263$-14.295$-3.253$-8.131
Income Taxes$-1.348$-3.556$-11.036$-7.243$40.337$-4.743
Income After Taxes$-166.787$-11.146$-6.227$-7.052$-43.59$-3.388
Other Income------
Income From Continuous Operations$-166.787$-11.146$-6.227$-7.052$-43.59$-3.388
Income From Discontinued Operations-$72.486$22.562$12.06--
Net Income$-166.787$61.34$16.335$5.008$-43.59$-3.388
EBITDA$-143.293$16.484$8.993$13.636$29.133$32.812
EBIT$-167.098$-9.396$-14.17$-11.175$1.018$-3.449
Basic Shares Outstanding383737373636
Shares Outstanding383737373636
Basic EPS$-4.39$1.64$0.44$0.14$-1.21$-0.09
EPS - Earnings Per Share$-4.39$1.64$0.44$0.14$-1.21$-0.09
# 2020 2019 2018 2017 2016 2015
Current Ratio2.97244.30132.93242.15222.19182.4919
Long-term Debt / Capital0.08080.16830.13770.15060.17050.1913
Debt/Equity Ratio0.08790.21450.16890.1870.23760.2525
Gross Margin56.887457.642454.979353.356749.257149.3069
Operating Margin-63.2571-3.4719-5.4155-4.14210.2877-0.9674
EBIT Margin-63.2571-3.4719-5.4155-4.14210.2877-0.9674
EBITDA Margin-54.24546.09093.4375.05438.23229.2031
Pre-Tax Profit Margin-63.6496-5.4324-6.5976-5.2986-0.9192-2.2806
Net Profit Margin-63.139322.66536.2431.8563-12.3174-0.9503
Asset Turnover0.44450.32360.37090.38110.48730.4612
Inventory Turnover Ratio1.90112.86082.99942.30873.24322.6821
Receiveable Turnover8.44956.21056.64086.05956.6946.1021
Days Sales In Receivables43.197858.771654.963160.235854.526759.8154
ROE - Return On Equity-36.6668-1.8129-1.1476-1.3692-8.5938-0.6215
Return On Tangible Equity-291.4786-9.1539-4.3212-87.062211.5915-154.3503
ROA - Return On Assets-28.0685-1.3326-0.8827-0.9961-6.0025-0.4383
ROI - Return On Investment-33.7031-1.5078-0.9896-1.163-7.1282-0.5027
Book Value Per Share11.945516.345414.576513.980113.981715.1834
Operating Cash Flow Per Share-1.3822-0.1148-0.40880.2720.53060.0234
Free Cash Flow Per Share-1.4896-0.1335-0.39130.25430.78530.0196